Filing Flows › Cardio Diagnostics Holdings (CDIO) › Q2 2026 › vs Q1 2026
Cardio Diagnostics Holdings (CDIO) Q2 2026 vs Q1 2026 (quarter over quarter)
Cardio Diagnostics Holdings's revenue rose $3K (+100%) from $3K in Q1 2026 to $5K in Q2 2026.
Cardio Diagnostics Holdings, Q2 2026: revenue $5K (-28% year over year), net loss $1.5M, operating cash flow −$1.3M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $5K | $3K | $3K | +100% |
| Net loss | $1.5M | $1.8M | −$287K | -16% |
| Costs & expenses | $1.5M | $1.8M | −$284K | -16% |
| Operating costs | $1.5M | $1.8M | −$284K | -16% |
| Interest & other, net | $3K | $3K | $0 | 0% |
| Research & development | $163K | $130K | $33K | +26% |
| Sales & marketing | $190K | $197K | −$7K | -3% |
| General & admin | $1.1M | $1.5M | −$311K | -21% |
| Other operating costs | $6K | $6K | $61 | +1% |
| Operating cash sources | $1.5M | $1.8M | −$287K | -16% |
| Depreciation & amortization | $6K | $6K | $61 | +1% |
| Share-based compensation | $24K | $25K | −$381 | -2% |
| Working capital & other | $129K | $196K | −$67K | -34% |
| Cash used in operations | $1.3M | $1.6M | −$220K | -14% |
| Net loss absorbed | $1.5M | $1.8M | −$287K | -16% |
Questions
How much did Cardio Diagnostics Holdings's revenue grow quarter over quarter in Q2 2026?
Cardio Diagnostics Holdings's revenue rose $3K (+100%) from $3K in Q1 2026 to $5K in Q2 2026.